ROYALTY PHARMA PLC Royalty Pharma PLC is a security (CUSIP 78081BAV5) tracked across SEC portfolio filings. 3 registered fund positions totaling $4.3M via N-PORT as of 2026-04-30.
| Fund | Registrant | Value | % of fund |
|---|---|---|---|
| DoubleLine Core Fixed Income Fund | DoubleLine Funds Trust | $2.9M | 4.20% |
| Nomura Extended Duration Bond Fund | Delaware Group Income Funds | $1.3M | 50.99% |
| RiverNorth/DoubleLine Strategic Income Fund | RIVERNORTH FUNDS | $122K | 1.22% |